Cargando…
Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman
OBJECTIVES: Totally implantable central venous access ports (port-a-caths) are increasingly used for the safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns of complications, reasons for premature removal and the duration of the use o...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968907/ https://www.ncbi.nlm.nih.gov/pubmed/33777430 http://dx.doi.org/10.18295/squmj.2021.21.01.014 |
_version_ | 1783666138972946432 |
---|---|
author | D’Souza, Philomena C. Kumar, Shiyam Kakaria, Annupam Al-Sukaiti, Rashid Al-Baimani, Khalid Hamid, Rana S. Mittal, Alok K. Al-Balushi, Muna Burney, Ikram A. Al-Moundhri, Mansour S. |
author_facet | D’Souza, Philomena C. Kumar, Shiyam Kakaria, Annupam Al-Sukaiti, Rashid Al-Baimani, Khalid Hamid, Rana S. Mittal, Alok K. Al-Balushi, Muna Burney, Ikram A. Al-Moundhri, Mansour S. |
author_sort | D’Souza, Philomena C. |
collection | PubMed |
description | OBJECTIVES: Totally implantable central venous access ports (port-a-caths) are increasingly used for the safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns of complications, reasons for premature removal and the duration of the use of port-a-caths in patients receiving cancer treatment at Sultan Qaboos University Hospital (SQUH) and compares the infection rate with the literature and the researchers’ experiences. METHODS: This retrospective follow-up study included patients who had received cancer treatment through a port-a-cath and were admitted to SQUH between January 2007 and April 2019. Demographic features, underlying diagnosis, clinical stage, treatment, duration of use and the cause of premature removal of the port-a-cath were recorded. RESULTS: A total of 516 port-a-caths were inserted in 482 cancer patients. The majority of devices were implanted by interventional radiologists (n = 459; 89.0%) and the right internal jugular vein was most frequently accessed (n = 396; 76.7%). The mean indwelling time of a port-a-cath was 288 days (range: 3–1,872 days) for patients with complications and 550 days (range: 7–3,123 days) for patients without complications. Port-a-cath-related infection was the main complication (n = 63; 12.2%). Patient age, gender, treatment intent, underlying diagnosis, clinical stage, chemotherapy regimen, number of treatment courses, operator implanting the port, the type of micro-organism isolated from the port-a-cath and body mass index were significant factors affecting catheter indwelling time (P <0.05). On multivariate analysis, however, none of the factors was found to be significant. CONCLUSION: Infection was the most common complication necessitating port-a-cath removal. The infection rate was much lower than the researchers’ previous experience and compares favorably with several published reports. |
format | Online Article Text |
id | pubmed-7968907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-79689072021-03-26 Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman D’Souza, Philomena C. Kumar, Shiyam Kakaria, Annupam Al-Sukaiti, Rashid Al-Baimani, Khalid Hamid, Rana S. Mittal, Alok K. Al-Balushi, Muna Burney, Ikram A. Al-Moundhri, Mansour S. Sultan Qaboos Univ Med J Clinical & Basic Research OBJECTIVES: Totally implantable central venous access ports (port-a-caths) are increasingly used for the safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns of complications, reasons for premature removal and the duration of the use of port-a-caths in patients receiving cancer treatment at Sultan Qaboos University Hospital (SQUH) and compares the infection rate with the literature and the researchers’ experiences. METHODS: This retrospective follow-up study included patients who had received cancer treatment through a port-a-cath and were admitted to SQUH between January 2007 and April 2019. Demographic features, underlying diagnosis, clinical stage, treatment, duration of use and the cause of premature removal of the port-a-cath were recorded. RESULTS: A total of 516 port-a-caths were inserted in 482 cancer patients. The majority of devices were implanted by interventional radiologists (n = 459; 89.0%) and the right internal jugular vein was most frequently accessed (n = 396; 76.7%). The mean indwelling time of a port-a-cath was 288 days (range: 3–1,872 days) for patients with complications and 550 days (range: 7–3,123 days) for patients without complications. Port-a-cath-related infection was the main complication (n = 63; 12.2%). Patient age, gender, treatment intent, underlying diagnosis, clinical stage, chemotherapy regimen, number of treatment courses, operator implanting the port, the type of micro-organism isolated from the port-a-cath and body mass index were significant factors affecting catheter indwelling time (P <0.05). On multivariate analysis, however, none of the factors was found to be significant. CONCLUSION: Infection was the most common complication necessitating port-a-cath removal. The infection rate was much lower than the researchers’ previous experience and compares favorably with several published reports. Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences 2021-02 2021-03-15 /pmc/articles/PMC7968907/ /pubmed/33777430 http://dx.doi.org/10.18295/squmj.2021.21.01.014 Text en © Copyright 2021, Sultan Qaboos University Medical Journal, All Rights Reserved This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nd/4.0/) . |
spellingShingle | Clinical & Basic Research D’Souza, Philomena C. Kumar, Shiyam Kakaria, Annupam Al-Sukaiti, Rashid Al-Baimani, Khalid Hamid, Rana S. Mittal, Alok K. Al-Balushi, Muna Burney, Ikram A. Al-Moundhri, Mansour S. Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman |
title | Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman |
title_full | Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman |
title_fullStr | Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman |
title_full_unstemmed | Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman |
title_short | Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman |
title_sort | complications and management of totally implantable central venous access ports in cancer patients at a university hospital in oman |
topic | Clinical & Basic Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968907/ https://www.ncbi.nlm.nih.gov/pubmed/33777430 http://dx.doi.org/10.18295/squmj.2021.21.01.014 |
work_keys_str_mv | AT dsouzaphilomenac complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman AT kumarshiyam complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman AT kakariaannupam complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman AT alsukaitirashid complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman AT albaimanikhalid complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman AT hamidranas complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman AT mittalalokk complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman AT albalushimuna complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman AT burneyikrama complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman AT almoundhrimansours complicationsandmanagementoftotallyimplantablecentralvenousaccessportsincancerpatientsatauniversityhospitalinoman |